Matthias Karasek

Research activity per year

If you made any changes in Pure these will be visible here soon.

2021
Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany
Ressler, J. M., Karasek, M., Koch, L., Silmbrod, R., Mangana, J., Latifyan, S., Aedo-Lopez, V., Kehrer, H., Weihsengruber, F., Koelblinger, P., Posch, C., Kofler, J., Michielin, O., Richtig, E., Hafner, C. & Hoeller, C., 19 Feb 2021, In: Journal for ImmunoTherapy of Cancer. 9, 2, e001701.
Research output: Journal article (peer-reviewed) › Journal article

Open Access
16 Citations (Scopus)
2019

1343P - Real life use of talimogene laherparepvec in melanoma in centers in Austria and Switzerland
Hoeller, C., Ressler, J. M., Karasek, M., Lopez, V. A., Koch, L., Kehrer, H., Koelblinger, P., Weihsengruber, F., Kofler, J., Richtig, E., Michielin, O. A. & Hafner, C., 1 Oct 2019, In: Annals of Oncology. 30, p. v548-v549
Research output: Journal article (peer-reviewed) › Conference contribution to journal

Research output